LncRNA IGF2AS was first identified as a cancer regulator in Wilm's tumours, a recent study showed that inhibiting endogenous lncRNA IGF2AS can promote neuronal growth and protect local anaesthetic‐induced neurotoxicity in DRG neurons 42. Here, IGF2-AS is linked to cancer.